Clik here to view.
Johnson & Johnson loses another pelvic mesh suit
A federal jury in Georgia deliberated for 3 hours yesterday before delivering another loss to Johnson & Johnson (NYSE:JNJ) in a product liability lawsuit brought over pelvic mesh products. The jury...
View ArticleClik here to view.
Johnson & Johnson’s $5m mesh settlement could push costs higher
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon could be facing a steeper-than-expected tab when it comes to settling the more than 46,000 product liability lawsuits brought over its pelvic mesh...
View ArticleClik here to view.
Report: Feds impanel grand jury in Boston Scientific pelvic mesh probe
A federal probe into allegations that Boston Scientific (NYSE:BSX) used counterfeit resin to make pelvic mesh products has reportedly convened a grand jury in West Virginia that’s already sent out...
View ArticleClik here to view.
C.R. Bard settles clutch of pelvic mesh lawsuits
A West Virginia federal judge yesterday dismissed nearly 150 product liability lawsuits brought against C.R. Bard (NYSE:BCR) over its pelvic mesh products, after an appeals court earlier this year...
View ArticleClik here to view.
Endo’s AMS claims pelvic mesh plaintiffs scammed into needless explantation...
Endo International (NSDQ:ENDP) subsidiary American Medical Systems Holdings repoortedly accused “a pyramid of businessmen, doctors and lawyers” of convincing women to undergo unnecessary surgeries to...
View ArticleClik here to view.
Kentucky joins Calif., Wash. state in suing J&J’s Ethicon over pelvic mesh
Kentucky joined California and Washington state in suing Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon over its pelvic mesh products, accusing the company of deceptively marketing its treatments...
View ArticleClik here to view.
Plaintiff’s loss overturned in Boston Scientific pelvic mesh lawsuit
The plaintiff in the 1st pelvic mesh lawsuit to go to trial against Boston Scientific (NYSE:BSX) won a new trial yesterday when a Massachusetts appeals court overturned a 2014 verdict dismissing the...
View ArticleClik here to view.
Boston Scientific loses bid to toss $19m pelvic mesh loss
Boston Scientific (NYSE:BSX) yesterday lost its bid to overturn an $18.5 million loss in a product liability lawsuit brought by a quartet of women alleging that its Obtryx pelvic mesh caused their...
View ArticleClik here to view.
Court quashes American Medical Systems subpoenas in pelvic mesh case, to mull...
The federal court overseeing the multidistrict litigation over pelvic mesh products made by American Medical Systems, the erstwhile women’s health business once owned by Endo International (NSDQ:ENDP),...
View ArticleClik here to view.
Appeals court upholds $3m verdict against J&J’s Ethicon in pelvic mesh case
A federal appeals court yesterday upheld a $3.3 million verdict against Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon in a product liability lawsuit brought over its TVT-O pelvic mesh. A jury in...
View ArticleClik here to view.
Johnson & Johnson loses $20m verdict in 3rd pelvic mesh bellwether
A Pennsylvania state court jury dealt a $20 million blow to Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon last week in the 3rd pelvic mesh bellwether to go to trial in Philadelphia. The verdict,...
View ArticleClik here to view.
Appeals court upholds Boston Scientific win in pelvic mesh case
A federal appeals court yesterday upheld a win for Boston Scientific (NYSE:BSX) in a product liability lawsuit brought over its Uphold pelvic mesh. Plaintiff Martha Carlson alleged that her injuries...
View ArticleClik here to view.
J&J’s Ethicon asks Supreme Court to review $3m pelvic mesh loss
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon last week asked the U.S. Supreme Court to review a $3.3 million loss in a product liability lawsuit brought over its TVT-O pelvic mesh. A federal...
View ArticleClik here to view.
J&J’s Ethicon wins Philly pelvic mesh trial
A Pennsylvania state court jury reportedly cleared Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon in the 4th pelvic mesh bellwether to go to trial in Philadelphia, despite finding that the...
View ArticleClik here to view.
Bard, Covidien settle more than 130 pelvic mesh cases
C.R. Bard (NYSE:BCR) and several subsidiaries of Medtronic (NYSE:MDT) unit Covidien settled more than 130 product liability lawsuits brought over pelvic mesh products. The lawsuits were part of...
View ArticleClik here to view.
AdvaMed backs Johnson & Johnson in Supreme Court appeal of $3m pelvic mesh loss
The medical device industry’s largest national lobbying group, AdvaMed, is backing Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon in its appeal to the U.S. Supreme Court over a $3.3 million loss...
View ArticleClik here to view.
Supreme Court won’t review $3m pelvic mesh loss for J&J’s Ethicon
The U.S. Supreme Court yesterday declined to review a $3 million loss for Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon in a product liability lawsuit brought over its TVT-O pelvic mesh. A jury...
View ArticleClik here to view.
Court upholds $27m pelvic mesh verdict against Boston Scientific
A federal appeals court last week upheld a plaintiff’s $27 million win over Boston Scientific (NYSE:BSX) in a product liability lawsuit brought over its Pinnacle pelvic mesh. A Florida jury in November...
View ArticleClik here to view.
British health watchdog recommends vaginal mesh ban
A British health watchdog reportedly plans to recommend that the National Health Service there ban vaginal mesh implants to treat pelvic organ prolapse, citing “serious but well-recognized safety...
View ArticleClik here to view.
Johnson & Johnson’s Ethicon loses $35m pelvic mesh lawsuit
An Indiana jury hit Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon with a $35 million verdict in a product liability lawsuit brought over its Prolift pelvic mesh. Barbara Kaiser and her husband...
View ArticleClik here to view.
UPDATE: New Jersey jury hits BD subsidiary Bard with $68m pelvic mesh verdict
Updated to include a $35 million in punitive damage verdict released today. Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard was reportedly hit yesterday with a $33 million verdict in a...
View ArticleClik here to view.
60 Minutes to speak to Boston Scientific in coverage of pelvic mesh MDL
CBS’s 60 Minutes will speak to Boston Scientific (NYSE:BSX) this week as the news program covers the massive multi-district litigation over gynecological pelvic mesh implants. The program referred to...
View ArticleClik here to view.
Boston Scientific wins third Mass. pelvic mesh trial
Boston Scientific (NYSE:BSX) last week won the third Massachusetts trial of a product liability lawsuit brought over two of its pelvic mesh products. Ana Martinez and her husband Jose sued Marlborough,...
View ArticleClik here to view.
Here are the top 5 medtech stories of mid-2018
[Image by managing editor Chris Newmarker]A growing U.S. trade war with China and other countries casts a pall on medtech — and U.S. business in general — in mid-2018. The landscape of the medical...
View ArticleClik here to view.
Missouri appeals court revives pelvic mesh suit against BD’s Bard
A Missouri state appeals court last week revived a pelvic mesh product liability lawsuit against Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard, ruling that a lower court was wrong to...
View Article
